These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1692813)

  • 21. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of specific immunoglobulin A-secreting cells in peripheral blood after natural infection with Shigella sonnei.
    Orr N; Robin G; Lowell G; Cohen D
    J Clin Microbiol; 1992 Aug; 30(8):2165-8. PubMed ID: 1500527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains.
    Viret JF; Cryz SJ; Lang AB; Favre D
    Mol Microbiol; 1993 Jan; 7(2):239-52. PubMed ID: 7680409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ribosomal dysentery vaccine. IV. Study of the reactogenicity, antigenic and protective activity of Shigella sonnei ribosomes in monkey experiments].
    Dzhikidze EK; Kavtaradze KN; Levenson VI; Subbotina IuL; Fedosova VG
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jul; (7):53-9. PubMed ID: 7025529
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vector.
    Xu DQ; Cisar JO; Ambulos N; Burr DH; Kopecko DJ
    Infect Immun; 2002 Aug; 70(8):4414-23. PubMed ID: 12117952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies Elicited by the
    Micoli F; Rossi O; Conti V; Launay O; Sciré AS; Aruta MG; Nakakana UN; Marchetti E; Rappuoli R; Saul A; Martin LB; Necchi F; Podda A
    Front Immunol; 2021; 12():671325. PubMed ID: 34017343
    [No Abstract]   [Full Text] [Related]  

  • 27. Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine.
    Levenson VI; Egorova TP; Belkin ZP; Fedosova VG; Subbotina JL; Rukhadze EZ; Dzhikidze EK; Stassilevich ZK
    Infect Immun; 1991 Oct; 59(10):3610-8. PubMed ID: 1716612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers.
    Orr N; Katz DE; Atsmon J; Radu P; Yavzori M; Halperin T; Sela T; Kayouf R; Klein Z; Ambar R; Cohen D; Wolf MK; Venkatesan MM; Hale TL
    Infect Immun; 2005 Dec; 73(12):8027-32. PubMed ID: 16299296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.
    Kotloff KL; Losonsky GA; Nataro JP; Wasserman SS; Hale TL; Taylor DN; Newland JW; Sadoff JC; Formal SB; Levine MM
    Vaccine; 1995 Apr; 13(5):495-502. PubMed ID: 7639017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
    Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K
    Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.
    McKenzie R; Walker RI; Nabors GS; Van De Verg LL; Carpenter C; Gomes G; Forbes E; Tian JH; Yang HH; Pace JL; Jackson WJ; Bourgeois AL
    Vaccine; 2006 May; 24(18):3735-45. PubMed ID: 16095766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models.
    Orr N; Robin G; Cohen D; Arnon R; Lowell GH
    Infect Immun; 1993 Jun; 61(6):2390-5. PubMed ID: 8500877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA).
    Mancini F; Gasperini G; Rossi O; Aruta MG; Raso MM; Alfini R; Biagini M; Necchi F; Micoli F
    Sci Rep; 2021 Jan; 11(1):906. PubMed ID: 33441861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Local immunity in the parenteral immunization of guinea pigs with a ribosomal dysentery vaccine].
    Liubinskaia MM; Rukhadze EZ; Chernokhvostova EV; Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):55-9. PubMed ID: 3901625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acute-phase substances.
    Munoz C; Baqar S; van de Verg L; Thupari J; Goldblum S; Olson JG; Taylor DN; Heresi GP; Murphy JR
    Am J Trop Med Hyg; 1995 Jul; 53(1):47-54. PubMed ID: 7542845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients.
    Li A; Rong ZC; Ekwall E; Forsum U; Lindberg AA
    Scand J Infect Dis; 1993; 25(5):569-77. PubMed ID: 8284641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Content of A-, G- and M-class immunoglobulins in adults perorally immunized with a liver Sonne dysentery vaccine].
    Kuz'min SN; Belaia IuA; Birkovskiĭ IuE; Milovanova LP; Pavlova LI
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Sep; (9):47-52. PubMed ID: 371307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.